Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastases-free Survival”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT00929214
What this trial is testing

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)UnknownNCT00790244
What this trial is testing

A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall

Who this might be right for
Soft Tissue SarcomaNon Metastatic Disease
Oslo University Hospital 188
Testing effectiveness (Phase 2)Study completedNCT00463060
What this trial is testing

Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer

Who this might be right for
Cancer
Icahn School of Medicine at Mount Sinai 47
Testing effectiveness (Phase 2)WithdrawnNCT02014831
What this trial is testing

Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)

Who this might be right for
Squamous Cell Carcinoma of the Penis
Centre Leon Berard
Post-approval studies (Phase 4)UnknownNCT05229809
What this trial is testing

Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer

Who this might be right for
Gastric Carcinoma
Jie Li 212
Testing effectiveness (Phase 2)UnknownNCT04782765
What this trial is testing

Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma

Who this might be right for
Disease-free Survival Rate
Tianjin Medical University Cancer Institute and Hospital 59
Testing effectiveness (Phase 2)Study completedNCT03142516
What this trial is testing

FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status

Who this might be right for
Colorectal NeoplasmsColorectal CarcinomaColorectal Cancer Metastatic+1 more
Grupo Espanol Multidisciplinario del Cancer Digestivo 20
Testing effectiveness (Phase 2)UnknownNCT02595021
What this trial is testing

Total/Subtotal Colectomy in Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more
Shanghai Gynecologic Oncology Group 80
Not applicableStudy completedNCT04947020
What this trial is testing

DataBase for Analysis of Rectal Cancer Oncological Results

Who this might be right for
Rectal CancerMetforminOverall Survival+2 more
Jagiellonian University 2,443
Large-scale testing (Phase 3)Study completedNCT02260505
What this trial is testing

Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)

Who this might be right for
Gastrointestinal Stromal TumorsResected Gastrointestinal Stromal TumorsNon-metastatic+2 more
Centre Leon Berard 136
Large-scale testing (Phase 3)Study completedNCT00338286
What this trial is testing

Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Who this might be right for
Breast CancerNeoplasm Metastasis
Janssen Research & Development, LLC 2,098
Testing effectiveness (Phase 2)Ended earlyNCT04034251
What this trial is testing

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

Who this might be right for
Gastric AdenocarcinomaGastric CancerEsophagogastric Junction+1 more
National Cancer Institute (NCI) 12
Not applicableActive Not RecruitingNCT06527001
What this trial is testing

Mesenteric Lymph Node Metastasis and Nutritional Status After Bowel Resection for Ovarian Cancer

Who this might be right for
Progression-Free SurvivalOverall SurvivalNutrition Aspect of Cancer
Anhui Provincial Hospital 300
Not applicableStudy completedNCT02013297
What this trial is testing

Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)

Who this might be right for
Brain MetastasisSpinal TumorsLung Tumors+1 more
Centre Leon Berard 61
Not applicableActive Not RecruitingNCT02456389
What this trial is testing

Perioperative Risk Study

Who this might be right for
TumorsPrimary NeoplasmSecondary Neoplasm+1 more
Fox Chase Cancer Center 1,456
Not applicableNot Yet RecruitingNCT07556835
What this trial is testing

Outcomes After Liver and Biliary Resection at a High-Volume Center

Who this might be right for
Liver NeoplasmsHepatobiliary DiseasesCholangiocarcinoma+6 more
Azienda USL Toscana Centro 1,000
Large-scale testing (Phase 3)Looking for participantsNCT07426055
What this trial is testing

PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate BrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Not applicableStudy completedNCT02385604
What this trial is testing

The Predictive Value of CT-PET in Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
St. James's Hospital, Ireland 250
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789444
What this trial is testing

Sacituzumab Tirumotecan（Sac-TMT） and Brain Radotherapy for EGFR+ NSCLC With Brain Mets

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases From Non-small Cell Lung Cancer (NSCLC)EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer
Xiaorong Dong 53
Early research (Phase 1)Ended earlyNCT01032122
What this trial is testing

Rituximab in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Medical University of Vienna 9
Next Page